Catalyst Wire Dossier Catalyst Wire Dossier

Poteligeo

mogamulizumab · Kyowa Kirin Pharmaceutical Development Ltd
Drug timelines are a Plus or Pro feature.

15 regulatory and trial events tracked for Poteligeo, covering 2016-02-17 to 2026-04-09. Get the full timeline:

Most recent: Clinical Trial Update: Mogamulizumab and Brentuximab Vedotin in CTCL and Mycosis Fungoides [Phase 1]

See pricing